Discerning how and where products are discounted is an expensive headache for manufacturers
David Weiss, IntegriChain
Advertisement
Articles by David Weiss, IntegriChain
Advertisement
Latest Updated Articles
Use data analytics to monitor 340B discount drug pricingPublished: March 14th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B Drugs
2
Morris & Dickson Acquires Prodigy Health to Expand Specialty and Plasma Distribution Capabilities
3
Have 503B Outsourcing Facilities Truly Reduced US Drug Shortages?
4
Why Trust Is the Biggest Barrier to Supply Chain Transparency
5